Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

9.10
-0.0500-0.55%
Post-market: 9.06-0.0400-0.44%19:59 EDT
Volume:481.22K
Turnover:4.40M
Market Cap:35.29M
PE:- -
High:9.25
Open:9.25
Low:9.04
Close:9.15
52wk High:33.84
52wk Low:9.04
Shares:3.88M
Float Shares:3.88M
Volume Ratio:0.94
T/O Rate:12.41%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Morning Brief | October Hike Odds Near Seventy Percent As Nasdaq Falls Over One Percent; Cybersecurity Bucks The Trend, TSMC To Lift Prices Three To Six Percent Next Year

Options & Short Sell
·
Sep 24

Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled

TradingKey
·
Sep 24

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Sep 24

Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial

TIPRANKS
·
Sep 23

The Stock Market is Sleeping on the Next Big AI Catalyst

Dow Jones
·
Sep 23

Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments

MT Newswires Live
·
Sep 23

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Reuters
·
Sep 23

Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile

MT Newswires Live
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)

TIPRANKS
·
Sep 23

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.89%

TIPRANKS
·
Sep 23

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 22

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Stock News
·
Sep 22

Novo Nordisk (NVO) Receives a Hold from Jefferies

TIPRANKS
·
Sep 22

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
Sep 22

Hope Fuels Markets but Reality Could Bite

Dow Jones
·
Sep 22

Novo Nordisk Investor Day Disappointed

Dow Jones
·
Sep 22

Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio

MT Newswires Live
·
Sep 22

Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

TIPRANKS
·
Sep 22